Eintrag weiter verarbeiten
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7)
Gespeichert in:
| Zeitschriftentitel: | Journal of Translational Medicine |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , |
| In: | Journal of Translational Medicine, 12, 2014, Suppl 1, S. O7 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Springer Science and Business Media LLC
|
| Schlagwörter: |
| author_facet |
Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni |
|---|---|
| author |
Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni |
| spellingShingle |
Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni Journal of Translational Medicine Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) General Biochemistry, Genetics and Molecular Biology General Medicine |
| author_sort |
puzanov, igor |
| spelling |
Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni 1479-5876 Springer Science and Business Media LLC General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1186/1479-5876-12-s1-o7 Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) Journal of Translational Medicine |
| doi_str_mv |
10.1186/1479-5876-12-s1-o7 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc5LTU4NzYtMTItczEtbzc |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc5LTU4NzYtMTItczEtbzc |
| institution |
DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 |
| imprint |
Springer Science and Business Media LLC, 2014 |
| imprint_str_mv |
Springer Science and Business Media LLC, 2014 |
| issn |
1479-5876 |
| issn_str_mv |
1479-5876 |
| language |
English |
| mega_collection |
Springer Science and Business Media LLC (CrossRef) |
| match_str |
puzanov2014updatedresultsandcorrelativefdgpetanalysisofaphaseibstudyofvemurafenibandcobimetinibmekinhibitorgdc0973inadvancedbrafv600mutatedmelanomabrim7 |
| publishDateSort |
2014 |
| publisher |
Springer Science and Business Media LLC |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Translational Medicine |
| source_id |
49 |
| title |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_unstemmed |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_full |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_fullStr |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_full_unstemmed |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_short |
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_sort |
updated results and correlative fdg-pet analysis of a phase ib study of vemurafenib and cobimetinib (mek inhibitor [gdc-0973]), in advanced brafv600- mutated melanoma (brim7) |
| topic |
General Biochemistry, Genetics and Molecular Biology General Medicine |
| url |
http://dx.doi.org/10.1186/1479-5876-12-s1-o7 |
| publishDate |
2014 |
| physical |
O7 |
| description |
|
| container_issue |
Suppl 1 |
| container_start_page |
0 |
| container_title |
Journal of Translational Medicine |
| container_volume |
12 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792332690122342416 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:00:09.155Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Updated+results+and+correlative+FDG-PET+analysis+of+a+phase+IB+study+of+vemurafenib+and+cobimetinib+%28MEK+inhibitor+%5BGDC-0973%5D%29%2C+in+advanced+BRAFV600-+mutated+melanoma+%28BRIM7%29&rft.date=2014-01-01&genre=article&issn=1479-5876&volume=12&issue=Suppl+1&pages=O7&jtitle=Journal+of+Translational+Medicine&atitle=Updated+results+and+correlative+FDG-PET+analysis+of+a+phase+IB+study+of+vemurafenib+and+cobimetinib+%28MEK+inhibitor+%5BGDC-0973%5D%29%2C+in+advanced+BRAFV600-+mutated+melanoma+%28BRIM7%29&aulast=Ribas&aufirst=Antoni&rft_id=info%3Adoi%2F10.1186%2F1479-5876-12-s1-o7&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792332690122342416 |
| author | Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni |
| author_facet | Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni, Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni |
| author_sort | puzanov, igor |
| container_issue | Suppl 1 |
| container_start_page | 0 |
| container_title | Journal of Translational Medicine |
| container_volume | 12 |
| description | |
| doi_str_mv | 10.1186/1479-5876-12-s1-o7 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc5LTU4NzYtMTItczEtbzc |
| imprint | Springer Science and Business Media LLC, 2014 |
| imprint_str_mv | Springer Science and Business Media LLC, 2014 |
| institution | DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4 |
| issn | 1479-5876 |
| issn_str_mv | 1479-5876 |
| language | English |
| last_indexed | 2024-03-01T14:00:09.155Z |
| match_str | puzanov2014updatedresultsandcorrelativefdgpetanalysisofaphaseibstudyofvemurafenibandcobimetinibmekinhibitorgdc0973inadvancedbrafv600mutatedmelanomabrim7 |
| mega_collection | Springer Science and Business Media LLC (CrossRef) |
| physical | O7 |
| publishDate | 2014 |
| publishDateSort | 2014 |
| publisher | Springer Science and Business Media LLC |
| record_format | ai |
| recordtype | ai |
| series | Journal of Translational Medicine |
| source_id | 49 |
| spelling | Puzanov, Igor McArthur, Grant Gonzalez, Rene Pavlick, Anna Hamid, Omid Gajewski, Thomas F Yin, Ming Fredrickson, Jill Choong, Nicholas Ribas, Antoni 1479-5876 Springer Science and Business Media LLC General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1186/1479-5876-12-s1-o7 Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) Journal of Translational Medicine |
| spellingShingle | Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni, Journal of Translational Medicine, Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7), General Biochemistry, Genetics and Molecular Biology, General Medicine |
| title | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_full | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_fullStr | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_full_unstemmed | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_short | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| title_sort | updated results and correlative fdg-pet analysis of a phase ib study of vemurafenib and cobimetinib (mek inhibitor [gdc-0973]), in advanced brafv600- mutated melanoma (brim7) |
| title_unstemmed | Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7) |
| topic | General Biochemistry, Genetics and Molecular Biology, General Medicine |
| url | http://dx.doi.org/10.1186/1479-5876-12-s1-o7 |